Bank of America
INKT icon

Bank of America’s MiNK Therapeutics INKT Stock Holding History

Bank of America’s Portfolio INKT Stock Details INKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-568
Closed -$6.33K – 6284
2025
Q4 		$6.33K Hold
568
– – ﹤0.01% 6247
2025
Q3 		$7.95K Hold
568
– – ﹤0.01% 7235
2025
Q2 		$4.2K Sell
568
-189
-25% -$1.42K ﹤0.01% 7324
2025
Q1 		$6.54K Buy
757
+553
+271% +$4.93K ﹤0.01% 7184
2024
Q4 		$1.42K Hold
204
– – ﹤0.01% 7240
2024
Q3 		$1.53K Hold
204
– – ﹤0.01% 7169
2024
Q2 		$1.93K Sell
204
-110
-35% -$1.07K ﹤0.01% 7148
2024
Q1 		$2.85K Sell
314
-1,762
-85% -$16.3K ﹤0.01% 7078
2023
Q4 		$22.2K Sell
2,076
-464
-18% -$4.84K ﹤0.01% 6768
2023
Q3 		$27.9K Sell
2,540
-96
-4% -$1.56K ﹤0.01% 6652
2023
Q2 		$55.3K Buy
+2,636
New +$52.8K ﹤0.01% 6425
2023
Q1 		– Sell
-1
Closed -$26 – 8023
2022
Q4 		$26 Buy
+1
New +$23 ﹤0.01% 7926
2022
Q3 		– Hold
0
– – – 8009
2022
Q2 		– Sell
-200
Closed -$3.77K – 8178
2022
Q1 		$5K Buy
200
+15
+8% +$451 ﹤0.01% 7892
2021
Q4 		$8K Buy
+185
New +$22K ﹤0.01% 7738

Other funds holding INKT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LF
Longbow Finance Lutry, Switzerland $782M AUM 48.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
PP
Paladin Partners Hartland, Wisconsin $151M AUM
AGWCA
Annis Gardner Whiting Capital Advisors Tampa, Florida $666M AUM 28.24% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of America's INKT Position: Q1 2026 in Review

Bank of America sold out of MiNK Therapeutics (INKT) in Q1 2026, closing a stake of 568 shares — an estimated $6.33K sold.

Bank of America first reported a position in INKT in Q4 2021 and held it in 14 quarters. The position peaked at $55.3K in Q2 2023. 23 funds tracked by Wall St. Rank hold INKT as of Q1 2026.

  • Bank of America reported no remaining MiNK Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 568 MiNK Therapeutics shares in Q1 2026, an estimated $6.33K.
  • Bank of America first reported a position in MiNK Therapeutics in Q4 2021 and held it in 14 quarters.
  • Bank of America's MiNK Therapeutics position peaked at $55.3K in Q2 2023.
  • 23 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.